Skip to main content

Table 1 Baseline characteristics in subjects according to application of PBO

From: Efficacy and safety of prophylactic balloon occlusion in the management of placenta accreta spectrum disorder: a retrospective cohort study

Variable

PBO group (N = 57)

Control group (N = 228)

P-value

Maternal Age (years )

33.58 ± 4.05

34.37 ± 4.42

0.498

BMI (kg/m2)

25.67 ± 2.94

26.80 ± 3.34

0.561

Gestational weeks (weeks)

36.4 ± 1.63

36.34 ± 2.22

0.079

Gravidity (number)

4 (3–4)

4 (3–4)

0.605

Parity (number)

2 (2–3)

2 (2–2)

0.005

Abortion(number)

1 (0–2)

1 (1–2)

0.254

Prior CS (number)

1 (1–1)

1 (0–1)

0.001

Type of CS

   

Planed CS

50 (87.7%)

156 (68.4%)

0.004

Emergency CS

7(12.3%)

72 (31.6%)

 

Type of PAS

  

< 0.001

Placenta Accreta

2 (3.5%)

89 (39.0%)

 

Placenta Increta

23 (40.4%)

114 (50.0%)

 

Placenta Percreta

32 (56.1%)

25 (11.0%)

 

MRI invasion topography

N = 52

N = 210

 

MRI with S1 invasion

15 (28.8%)

150 (71.4%)

< 0.001

MRI with S2 invasion

37 (71.2%)

60 (28.6%)

< 0.001

  1. Note: The data were shown as median (interquartile range) or number (%)
  2. Abbreviations: PBO, prophylactic balloon occlusion; BMI, Body mass index ;CS, cesarean section; PAS, Placenta accreta spectrum; MRI, Magnetic resonance imaging